【摘 要】
：
Background:Chronic obstructive pulmonary disease (COPD) is a major health problem and a leading cause of mortality worldwide.A Significant number of patients with COPD exhibit skeletal muscle wasting
【机 构】
：
Department of Respiratory Medicine Orebro University Hospital Sweden
【出 处】
：
中国上海第七届国际新药发明科技年会
论文部分内容阅读
Background:Chronic obstructive pulmonary disease (COPD) is a major health problem and a leading cause of mortality worldwide.A Significant number of patients with COPD exhibit skeletal muscle wasting and decreased capillary area formation which have been correlated,collectively known as pulmonary cachexia syndrome (PCS),which was directly coupled to increased mortality.In a series of studies,we have recently investigated the molecular mechanisms mediating decreased capillary formation in COPD.
其他文献
Diabetes mellitus is a chronic disease which is estimated to affect more than 171 million people worldwide.Despite the recent clinical success of GLP-1 and DPP4-based treatments,the unmet medical need
Context and Objective:Thiazolidinediones (TZDs) inhibit estrogen production in ovarian cells.We explored whether TZDs affect aromatase activity.Materials & Methods:Human granulosa cells were incubated
1.Discovery of a new drug that treat insulin resistance,which is not a simple blood glucose lowering drug:We have discovered that Cyclo (his-pro) (CHP),a thyrotropin releasing hormone metabolite,stimu
This lecture will discuss the role of three mechanisms i.e.,poly(ADP-ribose) polymerase (PARP),12/15-1ipoxygenase (LO),and Na+/H+-exchanger-1 (NHE-1),in peripheral diabetic neuropathy (PDN).PARP catal
To keep blood glucose in normal level without stimulation of insulin Secretion is the effective therapy for diabetes owing to reduction of the burden for ?-cells.We found a novel diabetes-therapy base
Type 2 diabetes mellitus is associated with progressive decreases in pancreatic 8-cell function.Most patients thus require increasingly intensive treatment,including oral combination therapies followe
Dipeptidyl peptidase Ⅳ(DPPI-Ⅳ) inhibitors are emerging as a new class of therapetutic agents for the treatment of type 2 diabetes.The catalytic action of DPP-Ⅳ is the principle means of degradation of
Alzheimers disease (AD) is a neurodegenerative disorder leading to progressive loss of memory and cognitive abilities.Currently,there is no successful treatment for AD patients.In cooperation with JAD
The OBrien laboratory recently demonstrated that the expression of Heat Shock Protein 27 (HSP27) is reduced in human coronary arteries with atherosclerosis.Moreover,we showed that over-expression of H
Soluble guanylate cyclase (sGC) is a key signal-transduction enzyme in the cardiovascular system and activated by nitric oxide (NO).Nitroglycerin as a well known drug is used for more than a century t